arrow
H

Hidekatsu Nakai

faculty of medicine
H指数:27
被引数:2,332

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term progression-free survivors (“super responders”) to olaparib maintenance in recurrent ovarian cancer: a multicenter real-world study (KCOG-G2101s)

奥拉帕利维持治疗复发性卵巢癌中的长期无进展生存者(“超级应答者”):一项多中心真实世界研究(KCOG-G2101s)

2025-12-220
PRE
Clinical utility and characteristics of comprehensive genomic profiling tests in patients with gynecologic cancer: a multi-institutional survey in Kinki District, Japan

妇科癌症患者中综合基因组分型检测的临床应用价值与特点:日本近畿地区多机构调查

2025-07-220
PRE
Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors
2024-12-060
PRE
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study

尼拉帕尼在经过大量预处理的同源重组缺陷型卵巢癌患者中的应用: 一项多中心2期研究的最终结果

2024-01-010
OAAI
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study

日本铂类敏感性复发性卵巢癌患者的尼拉帕尼: 一项多中心2期研究的最终结果

2024-01-010
OAAI
CXCL13-producing CD4+T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

CXCL13-producing CD4 T细胞在卵巢癌三级淋巴结构的早期积累

2022-06-2296
OA
Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program

日本未接种疫苗的宫颈上皮内瘤变妇女中HPV16/18患病率的变化: HPV疫苗接种计划后的群体效应评估

2022-01-253
OAAI
The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study

日本年轻女孩接种人乳头瘤病毒疫苗的效果: 海洋研究的中期结果

2021-11-223
OAAI
Updated results of a phase 2 study of niraparib in heavily pretreated high-grade serous ovarian cancer patients in Japan
2021-07-010
PREAI
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

日本铂类敏感复发性卵巢癌患者维持尼拉帕尼安全性的2期单臂研究

2021-01-0110
OAAI
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

尼拉帕尼在日本经过大量预处理的同源重组缺陷型卵巢癌患者中的疗效和安全性的2期单臂研究

2021-01-0110
OAAI
A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?
2020-07-306
OAAI